Favia, M.; Gallo, C.; Guerra, L.; De Venuto, D.; Diana, A.; Polizzi, A.M.; Montemurro, P.; Mariggiò, M.A.; Leonetti, G.; Manca, A.;
et al. Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells. Int. J. Mol. Sci. 2020, 21, 2398.
https://doi.org/10.3390/ijms21072398
AMA Style
Favia M, Gallo C, Guerra L, De Venuto D, Diana A, Polizzi AM, Montemurro P, Mariggiò MA, Leonetti G, Manca A,
et al. Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells. International Journal of Molecular Sciences. 2020; 21(7):2398.
https://doi.org/10.3390/ijms21072398
Chicago/Turabian Style
Favia, Maria, Crescenzio Gallo, Lorenzo Guerra, Domenica De Venuto, Anna Diana, Angela Maria Polizzi, Pasqualina Montemurro, Maria Addolorata Mariggiò, Giuseppina Leonetti, Antonio Manca,
and et al. 2020. "Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells" International Journal of Molecular Sciences 21, no. 7: 2398.
https://doi.org/10.3390/ijms21072398
APA Style
Favia, M., Gallo, C., Guerra, L., De Venuto, D., Diana, A., Polizzi, A. M., Montemurro, P., Mariggiò, M. A., Leonetti, G., Manca, A., Casavola, V., & Conese, M.
(2020). Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells. International Journal of Molecular Sciences, 21(7), 2398.
https://doi.org/10.3390/ijms21072398
